Sign in

You're signed outSign in or to get full access.

Clay Hoffman

Research Analyst at Nicholas Hoffman & Company, LLC.

Clay Hoffman is an Analyst at Invitation Homes, specializing in real estate and investment analysis within the residential rental sector. During his tenure, he has evaluated assets for one of the largest single-family home leasing companies in the United States and contributed insights on regional investment opportunities. Hoffman began his career with roles at Mynd and later joined Invitation Homes, further advancing his expertise in investment management for institutional real estate portfolios. He holds relevant professional credentials corresponding to his responsibilities, with a background that spans management and analytical roles in real estate investment.

Clay Hoffman's questions to CHAMPIONS ONCOLOGY (CSBR) leadership

Question · Q1 2026

Clay Hoffman sought an update on Q2 fiscal 2026 revenue performance compared to the previous year, given the quarter was approximately halfway complete.

Answer

CFO David Miller confirmed that management has a good understanding of Q2 revenue but declined to provide specific guidance on exact numbers or percentages at this time. He reiterated the expectation for sequential quarterly revenue increases.

Ask follow-up questions

Fintool

Fintool can predict CHAMPIONS ONCOLOGY logo CSBR's earnings beat/miss a week before the call

Question · Q1 2026

Clay Hoffman requested an update on Q2 revenue performance compared to the previous year, given that the company was halfway through the quarter.

Answer

CFO David Miller stated that while the company has a good handle on Q2 revenue, specific guidance on exact numbers or percentages would not be provided. He reiterated the expectation for sequential quarterly revenue increases.

Ask follow-up questions

Fintool

Fintool can write a report on CHAMPIONS ONCOLOGY logo CSBR's next earnings in your company's style and formatting

Question · Q1 2026

Clay Hoffman requested an update on Champions Oncology's Q2 fiscal 2026 revenue performance, specifically asking for color on how it compares to the previous year, given that the company was halfway through the quarter.

Answer

CFO David Miller stated that while the company has a good handle on Q2 revenue, they are not providing specific guidance at this time. He reiterated the anticipation of quarterly revenue increases but declined to give exact numbers or percentages for the upcoming quarter.

Ask follow-up questions

Fintool

Fintool can auto-update your Excel models when CHAMPIONS ONCOLOGY logo CSBR reports